Krüppel-like factor 4 promotes c-Met amplification-mediated gefitinib resistance in non-small-cell lung cancer.

about

Krüppel-like factor 4 promotes c-Met amplification-mediated gefitinib resistance in non-small-cell lung cancer.

Item

http://www.wikidata.org/entity/Q52602513

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

KLF4 promotes c-Met amplification-mediated gefitinib resistance in NSCLC.

@nl

Krüppel-like factor 4 promotes ...... in non-small-cell lung cancer.

@en

type

Item

label

KLF4 promotes c-Met amplification-mediated gefitinib resistance in NSCLC.

@nl

Krüppel-like factor 4 promotes ...... in non-small-cell lung cancer.

@en

prefLabel

KLF4 promotes c-Met amplification-mediated gefitinib resistance in NSCLC.

@nl

Krüppel-like factor 4 promotes ...... in non-small-cell lung cancer.

@en

P1476

Krüppel-like factor 4 promotes ...... in non-small-cell lung cancer

@en

P2093

Chunle Wang

http://www.w3.org/2001/XMLSchema#string

Chunyun Li

http://www.w3.org/2001/XMLSchema#string

Longyu Jin

http://www.w3.org/2001/XMLSchema#string

Qianyi Xie

http://www.w3.org/2001/XMLSchema#string

Suo Liu

http://www.w3.org/2001/XMLSchema#string

Ying Ji

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial.

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.

Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes

EGFR-TKI resistance in NSCLC patients: mechanisms and strategies

Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells

Deficiency of the Kruppel-like factor KLF4 correlates with increased cell proliferation and enhanced skin tumorigenesis

Cancer statistics, 2016

Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma

P304

1775-1786

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.13601

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Wei Feng

P577

2018-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29624806

http://www.w3.org/2001/XMLSchema#string

P932

5989843

http://www.w3.org/2001/XMLSchema#string